Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1502285060HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

Allergan investors want up to $200 per share from Valeant

27.05.2014 / Fierce Pharma

Valeant Pharmaceuticals has already promised it will raise its $47 billion offer for Allergan Wednesday during a webcast for investors. But according to a JPMorgan survey, that new offer had better be at least $180 per share if the Canadian deal machine wants to make some headway.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: